Matches in Wikidata for { <http://www.wikidata.org/entity/Q63322137> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q63322137 description "clinical trial" @default.
- Q63322137 description "ensayu clínicu" @default.
- Q63322137 description "klinisch onderzoek" @default.
- Q63322137 description "клінічне випробування" @default.
- Q63322137 name "A Phase I/IIa Study of Human Anti-CD38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma" @default.
- Q63322137 type Item @default.
- Q63322137 label "A Phase I/IIa Study of Human Anti-CD38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma" @default.
- Q63322137 prefLabel "A Phase I/IIa Study of Human Anti-CD38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma" @default.
- Q63322137 P1050 Q63322137-3B14C8DB-9CBF-4F0C-B4AC-90A77009AD39 @default.
- Q63322137 P1132 Q63322137-DB0E703A-E2AD-47CB-B374-43CD772E9ABF @default.
- Q63322137 P1476 Q63322137-F07E60A0-EFB4-46FD-8F12-A469BF619022 @default.
- Q63322137 P17 Q63322137-8D269D78-48EA-4A5B-A6C6-1211D428136D @default.
- Q63322137 P17 Q63322137-FA3440D7-A98B-43DE-A6E5-EAA37619838F @default.
- Q63322137 P2899 Q63322137-E511D801-C131-4E2E-A96D-B46F9FD563D3 @default.
- Q63322137 P3098 Q63322137-FC4E2746-CFC9-402E-B7CF-28CDEE6B2AC9 @default.
- Q63322137 P31 Q63322137-6E5AAE67-1648-4070-B5BE-673BD86AD25C @default.
- Q63322137 P4844 Q63322137-175B386D-80F6-409E-A615-4F3BFA14247B @default.
- Q63322137 P4844 Q63322137-41FD31A3-679F-4C02-B8B9-4CE37F13359E @default.
- Q63322137 P4844 Q63322137-6AE3C3C6-98EE-4326-A45A-DD99E677946E @default.
- Q63322137 P4844 Q63322137-898E95F2-FA1F-404A-9E60-CBCD9D24B905 @default.
- Q63322137 P4844 Q63322137-B0765A0B-5CB9-4DAB-A06A-4056F1DAD150 @default.
- Q63322137 P580 Q63322137-CC474FD9-32A8-4E4F-AFCF-B806BEFE1DEC @default.
- Q63322137 P582 Q63322137-E4160DAA-F7ED-45CD-9AE6-545CBF9F79D7 @default.
- Q63322137 P6099 Q63322137-C69147E7-0B12-4602-8D28-2B3D88EED0B2 @default.
- Q63322137 P6099 Q63322137-CBBDAB09-77F1-412E-AF8A-1C3FD66B0330 @default.
- Q63322137 P8363 Q63322137-FC149512-A13E-4612-BD29-0F1437FC2A22 @default.
- Q63322137 P921 Q63322137-F8C880EF-6CA5-4827-A35E-204CC095C00C @default.
- Q63322137 P1050 Q467635 @default.
- Q63322137 P1132 "+121" @default.
- Q63322137 P1476 "A Phase I/IIa, Open-Label, Multicentre, Dose-Escalation Study to Evaluate the Safety and Preliminary Efficacy of the Human Anti-CD38 Antibody MOR03087 as Monotherapy and in Combination With Standard Therapy in Subjects With Relapsed/Refractory Multiple Myeloma" @default.
- Q63322137 P17 Q183 @default.
- Q63322137 P17 Q40 @default.
- Q63322137 P2899 "+18" @default.
- Q63322137 P3098 "NCT01421186" @default.
- Q63322137 P31 Q30612 @default.
- Q63322137 P4844 Q15889608 @default.
- Q63322137 P4844 Q203174 @default.
- Q63322137 P4844 Q408524 @default.
- Q63322137 P4844 Q425681 @default.
- Q63322137 P4844 Q7227206 @default.
- Q63322137 P580 "2011-07-01T00:00:00Z" @default.
- Q63322137 P582 "2017-12-01T00:00:00Z" @default.
- Q63322137 P6099 Q42824440 @default.
- Q63322137 P6099 Q5452194 @default.
- Q63322137 P8363 Q78089383 @default.
- Q63322137 P921 Q7227206 @default.